During the past decade, Hospital Juan Ramon Jimenez conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 17 clinical trials were completed, i.e. on average, 24.6% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 14 clinical trials were completed. i.e. 41.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Juan Ramon Jimenez" #1 sponsor was "PETHEMA Foundation" with 11 trials, followed by "Fundación EPIC" with 7 trials sponsored, "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 7 trials sponsored, "Fundación Pública Andaluza Progreso y Salud" with 6 trials sponsored and "Shire" with 6 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Juan Ramon Jimenez" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Medtronic" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Complejo Hospitalario de Especialidades Juan Ramón Jimenez" with 2 trials as a collaborator and "Dynamic Science S.L." with 2 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Juan Ramon Jimenez" are "Coronary Artery Disease" (9 trials), "Ulcerative Colitis" (8 trials), "Crohn's Disease" (6 trials), "Breast Cancer" (5 trials) and "Crohn Disease" (4 trials). Many other conditions were trialed in "Hospital Juan Ramon Jimenez" in a lesser frequency.

Most popular intervention types in "Hospital Juan Ramon Jimenez" are "Drug" (56 trials), "Device" (15 trials), "Other" (11 trials), "Procedure" (8 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ontamalimab" (4 trials), "Cyclophosphamide" (3 trials), "Azacitidine" (2 trials) and "Cx601" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Juan Ramon Jimenez" are 93 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Juan Ramon Jimenez". undefined are not yet recruiting, 26 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Hospital Juan Ramon Jimenez, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Juan Ramon Jimenez, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 11 trials that are defined as “Not Applicable".

Hospital Juan Ramon Jimenez has several departments that took part in Clinical trials: "Hospital Juan Ramon Jimenez;Servicio de Oncologia" - 3 trials